Dimaras H,Corson TW .2019 .Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res, 97(1) : 29-44.
Webb AH,Gao BT,Goldsmith ZK,Irvine AS,Saleh N,Lee RP .2017 .Inhibition of MMP and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer, 17(1) : 434.
Youssef NS,Said AM .2014 .Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies. Int J Clin Exp Pathol, 7(9) : 5725-37.
Kivelä T. .2008 .The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol, 93(9) : 1129-31.
Rushlow DE,Mol BM,Kennett JY,Yee S,Pajovic S,Thériault BL .2013 .Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol, 13(4) : 70045-7.
Bejjani A,Choi MR,Cassidy L,Collins DW,O'Brien JM,Murray T .2012 .RB116: an RB1+ retinoblastoma cell line expressing primitive markers. Mol Vis, 8(1) : 2805-13.
Athavale V,Khetan V .2018 .Kundson to embryo selection: a story of the genetics of retinoblastoma. Taiwan J Opthalmol, 37(1) : 18-20.
Thériault BL,Dimaras H,Gallie BL,Corson TW .2014 .The genomic landscape of retinoblastoma: a review. Clin Experiment Ophthalmol, 42(1) : 33-52.
Li J,Zhang Y,Wang X,Zhao R .2017 .MicroRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A. Oncol Lett, 13(6) : 5021-7.
Li Z,Li Q,Wang G,Huang Y,Mao X,Zhang Y .2017 .Inhibition of Wnt/β-catenin by anthelmintic drug niclosamide effectively targets growth, survival, and angiogenesis of retinoblastoma. Am J Transl Res, 9(8) : 3776-86.
Stenfelt S,Blixt MKE,All-Ericsson C,Hallböök F,Boije H. .2017 .Heterogeneity in retinoblastoma: a tale of molecules and models. Clin Transl Med, 6(1) : 42.
Gao J,Zeng J,Guo B,He W,Chen J,Lu F .2016 .Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine (Baltimore), 95(42) : .
Reddy SC,Anusya S. .2010 .Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients. Int J Ophthalmol, 3(1) : 64-8.
Abramson DH,Shields CL,Munier FL,Chantada GL .2015 .Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmo, 133(11) : 1341-7.
Dunkel IJ,Shi W,Salvaggio K,Marr BP,Brodie SE,Gobin YP .2014 .Risk factors for severe neutropenia following intraarterial chemotherapy for intra-ocular retinoblastoma. PLoS One, 9(10) : .
Creighton CJ,Fountain MD,Yu Z,Nagaraja AK,Zhu H,Khan M .2010 .Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res, 09(5) : 0008-5472.
Du M,Wang J,Chen H,Wang S,Chen L,Xu Y .2018 .MicroRNA 200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c Met signaling pathway. Oncology Rep, 41(1) : 1497-508.
Peng C,Li N,Ng YK,Zhang J,Meier F,Theis FJ .2012 .A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J Neurosci, 32(38) : 12-308.
Montoya V,Fan H,Bryar PJ,Weinstein JL,Mets MB,Feng G .2015 .Novel miRNA-31 and miRNA-200a-mediated regulation of retinoblastoma proliferation. PLoS One, 10(9) : .
Li D,Hu C,Li H C .2018 .: survivin as a novel target protein for reducing the proliferation of cancer cells (Review). Biomed Rep, 8(1) : 399-406.
Garg H,Suri P,Gupta JC,Talwar GP,Dubey S. .2016 .Survivin: a unique target for tumor therapy. Cancer Cell Int, 16(1) : 49.
Jaiswal PK,Goel A,Mittal RD .2015 .Survivin: a molecular biomarker in cancer. Indian J Med Res, 141(4) : 159250-5916.
Shehata HH,Ghalia AHA,Elsayed EK,Ziko OO,Mohamed SS .2009 .Detection of survivin protein in aqueous humor and serum of retinoblastoma patients and its clinical significance. Clin Biochem, 10(1) : 362-6.
Gibson VP,Hardy P,Chain JL .2019 .4:AB045. , : .
Ferrario A,Luna M,Rucker N,Wong S,Lederman A,Kim J .2016 .Targeting survivin enhances chemosensitivity in retinoblastoma cells and orthotopic tumors. PLoS One, 11(4) : .
Jeanne A,Schneider C,Martiny L,Dedieu S. .2015 .Original insights on thrombospondin-1-related antireceptor strategies in cancer. Front Pharmacol, 6(1) : 252.
Chen P,Yu N,Zhang Z,Zhang P,Yang Y,Wu N .2016 .Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair. Oncotarget, 7(5) : 6105-20.
Xu XL,Singh HP,Wang L,Qi DL,Poulos BK,Abramson DH .2014 .Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature, 514(7522) : 385-8.
Laurie NA,Shih CS,Dyer MA .2007 .Targeting MDM2 and MDMX in retinoblastoma. Curr Cancer Drug Targets, 7(7) : 689-95.
Qi DL,Cobrinik D. .2016 .MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene, 36(13) : 1760-9.
Folkman J.,Introduction J. .1990 .. Cancer Metastasis Rev, 9(3) : 171-4.
Garcia JR,Gombos DS,Prospero CM,Ganapathy A,Penland RL,Chevez-Barrios P .2015 .Expression of angiogenic factors in invasive retinoblastoma tumors is associated with increase in tumor cells expressing stem cell marker Sox2. Arch Pathol Lab Med, 139(1) : 1531-8.
Baumann P,Mandl-Weber S,Emmerich B,Straka C,Schmidmaier R .2007 .Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells. Exp Cell Res, 06(16) : 3592-603.
Rehman G,Shehzad A,Khan AL,Hamayun M. .2014 .Role of AMPactivated protein kinase in cancer therapy. Arch Pharm (Weinheim), 347(7) : 457-68.
Shaw RJ,Bardeesy N,Manning BD,Lopez L,Kosmatka M,DePinho RA .2004 .The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell, 06(1) : 91-99.
Theodoropoulou S,Kolovou PE,Morizane Y,Kayama M,Nicolaou F,Miller JW .2010 .Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J, 24(8) : 152546-30.
.2011 .also regulated by ADP? Trends Biochem Sci. , 06(9) : 470-7.
Vazquez-Martin A,Oliveras-Ferraros C,Menendez JA .2009 .The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle, 8(1) : 2385-98.
Shackelford DB,Shaw RJ .2009 .The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer, 9(8) : 563-75.
Theodoropoulou S,Brodowska K,Kayama M,Morizane Y,Miller JW,Gragoudas ES .2013 .Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis. PLoS One, 8(1) : .
Li Y,Li PK,Roberts MJ,Arend R,Samant RS,Buchsbaum DJ RS .2014 .Multi-targeted therapy of cancer by niclosamide: a new application for an old drug. Cancer Lett, 04(1) : 8-14.
Satoh K,Zhang L,Zhang Y,Chelluri R,Boufraqech M,Nilubol N .2016 .Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma. Clin Cancer Res, 15(14) : 1078-0432.
Pan JX,Ding K,Wang CY .2012 .Niclosamide, an old anti-helminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells. Chin. J. Cancer, 31(4) : 178-84.
Arend RC,Londoño-Joshi AI,Gangrade A,Katre AA,Kurpad C,Li Y .2016 .Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. Oncotarget, 7(52) : 86803-15.
Polakis P. Drugging .2012 .Wnt signalling in cancer. EMBO J, 31(12) : 2737-46.
Zhan T,Rindtorff N,Boutros M. .2016 .Wnt signaling in cancer. Oncogene, 36(1) : 1461-73.
Zhang Q,Cheng Y,Huang L,Bai Y,Liang J,Li X .2017 .Inhibitory effect of carboplatin in combination with bevacizumab on human retinoblastoma in an in vitro and in vivo model. Oncol Lett, 14(5) : 5326-32.
Lee SY,Kim DK,Cho JH,Koh JY,Yoon YH .2008 .Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma. Arch Ophthalmol, 126(7) : 953-8.
Heo JW,Kim JH,Cho CS,Jun HO,Kim DH,Yu YS .2012 .Inhibitory activity of bevacizumab to differentiation of retinoblastoma cells. PLoS One, 7(3) : .
Missotten GS,Schlingemann RO,Jager MJ RO .2010 .Angiogenesis and vascular endothelial growth factors in intraocular tumors. Dev Ophthalmol, 46(1) : 123-32.
Cheng Y,Zheng S,Pan CT,Yuan M,Chang L,Yao Y .2017 .Analysis of aqueous humor concentrations of cytokines in retinoblastoma. PLoS One, 12(5) : .
Avery RL,Pieramici DJ,Rabena MD,Castellarin AA,Nasir MA,Giust MJ MA .2005 .Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology, 11(1) : 363-72.
Ellis LM .2006 .Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer. Semin Oncol, 08(5 Suppl 10) : S1-7.
Kim JH,Kim JH,Kim DH,Cho CS,Jun HO,Yu YS .2009 .Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation. Tumour Biol, 30(5-6) : 233-41.
Srinivasan R,Zabuawala T,Huang H,Zhang J,Gulati P,Fernandez S .2009 .Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One, 4(12) : .
Chau CH,Figg WD .2012 .Aflibercept in pediatric solid tumors: moving beyond the trap. Clin Cancer Res, 12(18) : 1078-0432.
Ciombor KK .2014 .-a decoy VEGF receptor. Curr Oncol Rep, 16(2) : 368.
Ricci V,Ronzoni M,Fabozzi T.,Aflibercept T. .2015 .a new target therapy in cancer treatment: a review. Crit Rev Oncol Hematol, 07(3) : 569-76.
Kim SH,Kim CW,Jeon SY,Go RE,Hwang KA,Choi KC .2014 .Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models. Lab Anim Res, 30(4) : 143-50.
Areán C,Orellana ME,Abourbih D,Abreu C,Pifano I,Burnier MN .2009 .Expression of vascular endothelial growth factor in retinoblastoma. Arch Ophthalmol, 128(2) : 223-9.
Kim DY,Choi JA,Koh JY,Yoon YH .2016 .Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma. J Exp Clin Cancer Res, 35(1) : 171.
Ganai AA,Farooqi H .2015 .Bioactivity of genistein: a review of in vitro and in vivo studies. Biomed Pharmacother, 10(1) : 30-8.
Pavese JM,Farmer RL,Bergan RC .2010 .Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev, 29(3) : 465-82.
Banerjee S,Li Y,Wang Z,Sarkar FH. .2008 .Multi-targeted therapy of cancer by genistein. Cancer Lett, 03(2) : 226-42.
Wei D,Yang L,Lv B,Chen L .2017 .Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1. Mol Vis, 23(1) : 385-94.
Yang XW,Zhang LJ,Huang XH,Chen LZ,Su Q,Zeng WT .2013 .-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. Hepatol Res, 4(5) : 551-9.
Slusarz A,Shenouda NS,Sakla MS,Drenkhahn SK,Narula AS,Macdonald RS .2010 .Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res, 09(8) : 0008-5472.
Pratheeshkumar P,Budhraja A,Son YO,Wang X,Zhang Z,Ding S .2012 .Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One, 7(10) : .
Liu H,Zhou M. .2017 .Antitumor effect of quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways. BMC Complement Altern Med, 17(1) : 531.
Huang YC,Kuo CL,Lu KW,Lin JJ,Yang JL,Wu RS .2016 .18α-Glycyrrhetinic acid induces apoptosis of HL-60 human leukemia cells through caspases- and mitochondriadependent signaling pathways. Molecules, 21(7) : 872.
Song W,Zhao X,Xu J,Zhang H .2017 .Quercetin inhibits angiogenesismediated human retinoblastoma growth by targeting vascular endothelial growth factor receptor. Oncol Lett, 14(3) : 3343-8.